Trials / Completed
CompletedNCT02511418
Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study was done to determine whether Simvastatin (a medication commonly used to treat patients with high cholesterol levels in the blood increases blood flow to the kidneys and improves renal function in normal volunteers and patients with impaired renal function secondary to polycystic kidney diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Simvastatin |
Timeline
- Primary completion
- 2007-01-01
- First posted
- 2015-07-30
- Last updated
- 2023-03-16
Source: ClinicalTrials.gov record NCT02511418. Inclusion in this directory is not an endorsement.